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Apoptosis is a conserved form of programmed cell death firmly established in the aetiology, pathogenesis and treatment of many human diseases. Central to the core machinery of apoptosis are the caspases and their proximal regulators. Current models for caspase control involve a balance of opposing elements, with variable contributions from positive and negative regulators among different cell types and species 1 . To advance a comprehensive view of components that support caspase-dependent cell death, we conducted a genome-wide silencing screen in the Drosophila model. Our strategy used a library of double-stranded RNAs together with a chemical antagonist of Inhibitor of apoptosis proteins (IAPs) that simulates the action of native regulators in the Reaper and Smac (also known as Diablo) families 2 . Here we present a highly validated set of targets that is necessary for death provoked by several stimuli. Among these, Tango7 is identified as a new effector. Cells depleted for this gene resisted apoptosis at a step before the induction of effector caspase activity, and the directed silencing of Tango7 in Drosophila prevented caspasedependent programmed cell death. Unlike known apoptosis regulators in this model system 3 , Tango7 activity did not influence stimulus-dependent loss of Drosophila DIAP1 (also known as th and IAP1), but instead regulated levels of the apical caspase Dronc (Nc). Similarly, the human Tango7 counterpart, PCID1 (also known as EIF3M), impinged on caspase 9, revealing a new regulatory axis affecting the apoptosome.
Mammalian Smac proteins are thought to be functional orthologues of the Drosophila IAP antagonists referred to as RHG proteins (Reaper, Head involution defective, and Grim, as well as Sickle and Jafrac2) 3 . Therefore, we tested the possibility that a small molecule Smac-mimetic 4 might simulate the action of RHG proteins in Drosophila cells. Like RHG proteins 5 , the Smac-mimetic compound specifically bound DIAP1-a central brake against caspases 3 (Fig. 1a) . In Drosophila cell lines, the Smac-mimetic compound induced stereotypical apoptosis (Fig. 1b and Supplementary Movie 1), which was completely reversed either by peptide caspase inhibitors or by RNA interference (RNAi) depletion of the apical caspase Dronc (Fig. 1c) , mirroring haemocytes lacking apoptosomal genes 6, 7 . Together, the findings establish the Smac-mimetic compound as a molecular mimetic of RHG proteins.
We conducted an RNAi-based genome-scale screen to identify essential apoptotic determinants using the Smac-mimetic compound as a proximal apoptogenic stimulus ( Fig. 2a and Methods). Our platform used S2R1 cells and a library of double-stranded (ds)RNAs targeting 13,071 annotated genes in Drosophila genome build 3 ( Fig. 2a and Methods) to capture targets that prevent Smac-mimetic-induced killing when silenced (Fig. 2c) . Each dsRNA (Supplementary Table 4) was tested in triplicate. The effects were typically reproducible (Fig. 2b) , and assay quality, measured by Z-factor values, was consistently high 8 .
Using both plate and position mean-centring analyses (Methods), we identified 42 candidate genes with protective activity that met or exceeded a stringent z-score $3.1 threshold (P , 0.001). This collection includes the expected benchmark targets Dronc, Dark (also known Caspase activity was measured 6 h after treatment with 90 mJ cm 22 UVC or 250 mM cycloheximide. The percentage of caspase activity was calculated relative to control mean (100%) for each experiment. Data shown are the mean percentage inhibition 6 s.d. from two independent experiments (n 5 3 wells for each experiment). P values for two-tail t-tests were calculated by comparing the percentage inhibition of each gene with the control for each treatment. High consistency and reproducibility across amplicons indicate requisite functions in apoptosis. * Human genes involved in cell death/survival pathways. { Only amplicon 1 significantly affects ultraviolet-stimulated caspase activation. The specificity of amplicon 1 or ATPa to rescuing ATP viability and caspase activation has not been tested.
as Ark) and the effector caspase Drice (also known as Ice) (Fig. 2c , Table 1 and Supplementary Table 1) .
Thirty-three of the 42 candidate genes with a z-score greater than 3.1 were retested using a different dsRNA amplicon (Fig. 2d) 
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. To examine the biological relevance of this threshold, 42 targets conferring less potent activity (2.1 , z , 3.1) were also retested (Supplementary Table 2 ). Nineteen candidates retested at least 3.1 standard deviations above the control mean, 16 of which had z . 3.1 in the original screen, whereas only three that survived this retest standard originally had 2.1 , z , 3.1. Hence, our initial z-score threshold was experimentally relevant and predictive for reproducibility across different dsRNA amplicons.
We selected a set of 13 priority targets (Table 1) for further characterization on the basis of conservation and/or suggested links to human disease or development. For these, our validation strategy applied different assay methods, distinct apoptotic triggers and alternative non-overlapping dsRNAs 10, 11 . We assessed new amplicons targeting each candidate by measuring effector caspase activity after ultraviolet light or cycloheximide challenge, two well-established apoptotic stimuli 12 . These data (Table 1 ) discriminate several target groups including (1) genes that exert substantial activity across several stimuli (Drice, Hrb27C, enok and Tango7), (2) stimulus-dependent genes (CG32626 and CG7275), and (3) genes with mild but statistically significant activity (SNF4Ac, eIF5 and sktl).
Depletion of Tango7 (CG8309) prevented killing induced by several apoptotic stimuli. Non-overlapping dsRNAs that target this gene (Tango7 dsRNA1 and dsRNA2) conferred protective activity comparable to benchmark amplicons that silence Dronc and Dark (Table 1 and Fig. 3b) . When tracked over a 22 h time course after ultraviolet challenge, more than 95% of control cells initiated blebbing and died. However, like samples depleted for Dronc, cells that were silenced for Tango7 were similarly prevented from apoptotic blebbing when directly visualized over this same period ( . Transgenic dsRNAs silencing Tango7 (e) or an irrelevant control (5887R1) (d) were targeted using the gmr-GAL4 eye 'driver' (see refs 13, 14 and Methods) . Extra interommatidial cells shown (e, outlined red) are from Tango7R1. f, In control retinas, most (63%) hexagonal assemblies had stereotypical numbers of interommatidial cells (15) . Less than 5% showed $17 cells per ommatidia (n 5 87). Tango7R1 produced 28% of ommatidia with $17 cells (n 5 118), and a minority (40%) showed stereotypical numbers. Tango7R3 produced 77% of ommatidia bearing $16 cells (n 5 62). Differences between control and Tango7 are significant by two-tailed unpaired t-test (Tango7R1 P 5 0.0002; Tango7R3 P , 0.0001). 14 .
activity) assays in Fig. 3b , our results indicate that Tango7 acts before effector caspase activation and before steps involved in apoptotic blebbing.
The combined results from several amplicons and three distinct assays validate Tango7 as an apoptogenic effector in S2R1 cells. To test the relevance of Tango7 during programmed cell death (PCD) in vivo, Tango7 dsRNAs were targeted to the pupal retina where excessive interommatidal cells are eliminated through caspase-dependent cell death 3 . Two different insertions of the 8309R1 transgene (Tango7R1 and Tango7R3) were compared to an irrelevant control dsRNA transgene (Methods). Like retinas mutated for apical or effector caspases 13, 14 , retinas expressing either Tango7R1 or Tango7R3 retained statistically significant numbers of extra interommatidial cells (Fig. 3d-f) . This effect was similar to animals lacking Drice 14 and was not seen with an irrelevant dsRNA strain from the same collection. Depletion of Tango7 in the wing also prompted a range of defects that were consistent with failures in post-eclosion cell death and similar to canonical PCD mutants 6, 13, 15, 16 ( Supplementary Fig. 1a-d) . Supplementary Fig. 1e, f) , and hence extra interommatidial cells could conceivably arise through activity unrelated to cell death. However, because scars are not evident in pupal stages, these infrequent defects manifest long after pruning of interommatidial cells, and are more likely to reflect pleiotropic roles for Tango7 in cells that are not fated to die.
To investigate the mode of apoptosis regulation by Tango7, core determinants were investigated. Notably, Tango7 did not affect basal or stimulus-dependent loss of DIAP1 protein levels (Fig. 4a) -a central point of control commonly observed during canonical apoptosis signalling in Drosophila 3 . Levels of the apoptosomal protein Dark were also unaffected (Fig. 4a) . In contrast, silencing of Tango7 caused a marked decline in pro-Dronc levels (Fig. 4b) . This relationship was also observed in the Dark-depleted state (Fig. 4b) , which causes pro-Dronc accumulation to unusually high steady-state concentrations 17 . Therefore, under a wide dynamic range, Tango7 positively regulates levels of this caspase. The findings also implicate a post-transcriptional mechanism linking Tango7 activity to Dronc protein levels, because within the limits of our semiquantitative PCR with reverse transcription (RT-PCR) assay, the treatments had little or no effect on Dronc messenger RNA abundance (Fig. 3c) .
To examine whether the relationship between Tango7 and Dronc (Fig. 4b) reflects a conserved regulatory axis, we tested whether PCID1-the human orthologue of Tango7-might similarly affect caspase 9. Human T98G cells 18 or IMR90E1A cells 19 were treated with gene-specific short-interfering (siRNAs), and steady-state levels of pro-caspase 9 were determined. As in Drosophila, a similar relationship between human counterparts was exposed in cell lines of distinct origins (Fig. 4c) . Here, PCID1 siRNAs caused a repression of procaspase 9 levels, with effects that were analogous to siRNAs that directly target caspase 9. To explore the links between PCID1 and apoptosis further, siRNA-treated cells were challenged with an apoptogenic stimulus (ultraviolet light) and tested for induction of effector caspase activity. As shown in Fig. 4d , silencing either PCID1 or CASP9 attenuated stimulus-dependent DEVDase. Furthermore, co-silencing of both targets reduced activity comparable to depletion of the pro-apoptotic effector, Bak 20 . Hence, in cells in which the levels of caspase 9 are rate-limiting, PCID1 is a relevant determinant of caspase activity. We also measured ATP in these experiments (data not shown), and by this criterion, neither CASP9 siRNAs nor PCID1 siRNAs appeared cytoprotective. However, this result was anticipated, because unlike caspase-inhibited fly cells 3 , mammalian cells often die by alternate forms of cell death when caspase activity is blocked 20, 21 . The highly validated gene set in Table 1 presents new opportunities for understanding how cells integrate death signals and execute apoptogenic responses. Like all RNAi screens, only rate-limiting targets were captured and Drosophila effectors not present in S2R1 cells were missed. Of note, Dark, Dronc and Drice dsRNAs were recovered among the top candidates, providing reassurance for the logistics of our platform. Targets recovered through our screen exposed previously unknown modalities that support apoptosis, but the extent to which most of these generalize beyond the original Drosophila culture system is not known. In principle, even the effector featured here, Tango7, might regulate caspase-dependent cell . The asterisk denotes a nonspecific, anti-DIAP1 band as a loading control. b, S2R1 cells treated with indicated dsRNAs were probed with anti-Dronc antibody. The asterisk denotes a nonspecific band as a loading control. In three independent experiments, compared to control (AmpR32, see Methods), relative reductions in pro-Dronc band intensity for Tango7 1 1 AmpR and Tango7 2 1 AmpR were 63-86% and 53-85%, respectively. Compared to the Dark 1 AmpR-treated cells, relative reductions in band intensity for cosilencing Tango7 1 1 Dark and Tango7 2 1 Dark were 36-61% and 33-54%, respectively. c, Human T98G or IMR90E1A cells were treated with siRNAs targeting PCID1 (PCI), CASP9 (C9), or a non-target control (C). Procaspase 9 (FL C9), cleaved caspase 9 (arrowhead) and PCID1 were detected. Asterisks denote nonspecific, loading-control bands. Two independent trials with the T98G line (T98G(t1) and T98G(t2)) are shown. d, IMR90E1A cells transfected with siRNAs targeting PCID1, CASP9, Bak or Bax were subsequently UV-challenged and assayed for DEVDase activity. C9/PCI samples received siRNAs targeting both CASP9 and PCID1. Triplicate data were normalized against cells transfected with non-targeting control siRNAs (C) treated in parallel. Error bars show s.d. *P , 0.05, **P , 0.01, Student's t-test (two-tailed). Three independent trials gave similar results. C9 or PCI siRNAs had negligible effects on basal DEVDase, because in the absence of UV challenge, DEVDase activity varied on average 2.3% (C9 siRNA) or 1.6% (PCI siRNA) relative to control.
death and Dronc only in S2R1 cells. However, this is quite unlikely for at least two reasons. First, when Tango7 is silenced in the retina, the exact same cells that persist are those that are known to die via caspase-dependent, canonical pathways. Second, our Drosophila studies successfully predicted cross-species apoptogenic activity for the counterpart of Tango7 in human cells of distinct origin.
Tango7 depletion uniquely illustrates how cell survival can be sustained (despite stimulus-dependent loss of DIAP1, Fig. 4a) , exposing a new axis of regulation that bypasses a common apoptotic switch in flies and, instead, affects the apoptosome 3 . We found no evidence for a physical association between Tango7 and Dronc protein (data not shown), and despite less severe effects on proDronc levels, rescue by dsRNAs targeting Tango7 were generally comparable to those targeting Dronc. Hence, Tango7 could affect the post-translational processing or sub-cellular localization of pro-Dronc. Alternatively, Tango7 could impact other apoptotic effectors, exerting affects beyond simply Dronc regulation. Consistent with these possibilities, Tango7 was linked to Golgi activity 22 , but because genes needed for general Golgi functions were not recovered here, links between Tango7 and Dronc evidently do not reflect compromised Golgi. Whatever the mechanism, this regulatory axis seems to be conserved because the human Tango7 counterpart, PCID1, similarly regulated caspase 9 levels and DEVDase in human cells (Fig. 4c) . In a recent study of pancreatic cancers 23 , PCID1 expression was repressed at least sixfold in all five patient tumours profiled. Furthermore, PCID1 was also implicated as a determinant of herpes simplex virus susceptibility 24 . It will be important to determine whether these possible links to human disease reflect apoptosisrelated activity or, perhaps, non-apoptotic functions reported for caspase 9 (ref. 25) .
METHODS SUMMARY
RNAi screen and validation. Eighteen-thousand cells in serum/antibiotic-free Schneider's media were seeded in each well containing 0.5 mg dsRNA (Ambion Silencer RNAi library or synthesized dsRNA), and incubated for 1 h before adding 100 ml serum-supplemented media. After 3 days, the media was replaced with Smac-mimetic-containing media. Cell viability was assayed 2 days later using CellTiter-Glo (Promega) in a plate reader (Envision multimode). Every assay plate included four control wells containing Dronc dsRNA. Of the 429 sample plates assayed in the screen, 76% (325 plates) had excellent assay quality (Z $ 0.5) and only 2% were unacceptable (Z , 0). The Z-factor for each plate 8 and plate mean-centred z-score for each well (n 5 92 sample wells) were calculated. To correct for systematic bias/edge effects 26 , the position mean-centred z-score for each well is calculated by its plate mean-centred z-score minus the position average, divided by the position standard deviation (n 5 143 plates per triplicate). Genes with z . 3.1 (P , 0.001) from either plate mean or position mean-centred normalizations were considered together as primary candidates. For secondary screens and subsequent RNAi experiments, dsRNA synthesis and treatment were as described 9, 27 (Supplementary Table 3 ). In brief, cells were cultured for 72 h to deplete target gene product before analysis. Effector caspase (DEVDase) activity was measured using Caspase3/7-Glo (Promega) 6 h after apoptosis stimulation.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Fly stocks. Tango7R1 denotes the GAL4-responsive RNAi line targeting CG8309 with a genotype w; P{UAS-8309R-1}2 on the second chromosome (NIG). This transgene was mobilized by standard methods and an insertion, designated Tango7R3, was recovered on the third chromosome. 3523R2 denotes the GAL4-responsive CG3523 RNAi line w; P{UAS-3523R-2}3 (stock ID 3523R-2, NIG). 5887R1 denotes the GAL4-responsive CG5887 RNAi line w; P{UAS-5887R-1} (stock ID 5887R-1, NIG). For pupal eye analyses, genotypes for Tango7 are UAS-dicer2/1; gmr-GAL4/UAS-Tango7R1, or UAS-dicer2/1; gmr-GAL4/1; UAS-Tango7R3/1; or as control, UAS-dicer2/1; gmr-GAL4/UAS-5887R1. The three independent wing-specific vestigial-GAL4 driver lines, vg-GAL4#1 ). Relative changes in band intensity were obtained by comparing integrated densitometric values. Human cells were collected 5 days after siRNA transfection, and 10 mg total protein was separated by 10% SDS-PAGE. Caspase 9 and PCID1 levels were analysed using anti-caspase 9 (Cell Signaling) and anti-PCID1 (Proteintech Group, Inc.) antibodies. Smac-mimetic binding. Cells were lysed in 20 mM HEPES-potassium hydroxide, pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM sodium EDTA, 1 mM sodium EGTA, 1 mM dithiothreitol (buffer A), 1% Triton X-100 buffer with protease inhibitors (Roche). Biotinylated-Smac-mimetic or biotin alone was incubated with avidinconjugated beads and 10 mg ml 21 BSA in PBS for 4 h at 4 uC. The beads were then incubated with precleared lysate (,1-2 mg protein) overnight before analysis. Primary and secondary RNAi screen. The primary screen was optimized for S2R1 cells and conducted using a 'direct soaking' protocol, together with the Silencer Drosophila RNAi library (Ambion/Applied Biosystems) targeting 13,071 genes from Drosophila genome build 3. Sequences for all dsRNAs in the library are available in Supplementary Table 4 . The RNAi library or synthesized dsRNAs were plated in 96-well microplates (Corning) using Beckman FX liquid handlers. Every assay plate included four control wells containing Dronc dsRNA. Each well contained 0.5 mg dsRNA in 20 ml of SF900 media. Eighteen-thousand cells in 30 ml serum/antibiotic-free Schneider's media were seeded into each well and incubated for 1 h before adding 100 ml media. After 3 days, the media was replaced with 80 ml 2.5 mM Smac-mimetic media. Cell viability was assayed 2 days later using CellTiter-Glo (Promega) in a plate reader (Envision multimode). The plate mean-centred z-score for each well is its luminescence value minus the plate average, divided by the plate standard deviation (n 5 92 sample wells). The Z-factor for each plate was calculated as described 8 . Low quality (Z , 0) plates were excluded from subsequent secondary retests and analyses. To correct for systematic bias/edge effects 26 , the position mean-centred z-score for each well is calculated by its plate mean-centred z-score minus the position average, divided by the position standard deviation (n 5 143 plates per triplicate). Average position mean-centred z-score for each amplicon is calculated from the individual position mean-centred z-scores of the triplicates. Genes with z . 3.1 from either plate mean or position mean-centred normalizations were considered together as primary candidates. For secondary screens and subsequent RNAi experiments, dsRNA synthesis and treatment was as described 9, 27 (Supplementary Table 3 ). Cells were cultured for 72 h to deplete target gene product before analysis. Effector caspase (DEVDase) activity was measured using Caspase3/7-Glo (Promega) 6 h after apoptosis stimulation according to manufacturer's instructions. Time-lapse microscopy. Cells pretreated with dsRNAs were tracked by timelapse microscopy for 22 h after ultraviolet exposure (90 mJ cm 22 UVC). Photomicrographs were captured at 6-min intervals on a Zeiss Axiovert 200M inverted microscope equipped with a Marzhauser programmable stage, a Nikon DXM1200F camera and controlled by Metamorph software (Molecular Devices). Movie images were assembled and analysed using ImageJ (NIH). At least 100 cells were tracked in each treatment. Dead cells are scored by morphology of rounding up, blebbing or fragmentation into corpses. Pupal eye analyses. White prepupae were isolated at 0 h and aged 46-48 h at 25 uC. To outline cell borders, pupal eyes were dissected and stained with mouse anti-DiscsLarge (Developmental Studies Hybridoma Bank, 1:1,000) and antimouse Fluorecein (Vector Laboratories, 1:250) as described previously 6, 15 . Interommatidial cell counts were modified from ref. 30. Hexagonal units connecting six 'ommatidia centres' that completely surround one ommatidium were counted. Secondary or tertiary pigment cells inside or partly inside hexagonal assemblies were counted as a single cell. siRNA transfection. siRNAs to CASP9 and PCID1 were ON-TARGETplus SMARTpool siRNA, and the control siRNA used was ON-TARGETplus Nontargeting pool (Dharmacon). T98G and IMR90E1A cells were transfected with 64 nM siRNAs targeting the genes indicated using Dharmafect Duo (Dharmacon) and Optimem according to manufacturer's instructions. Pools contain four siRNAs for each indicated gene. After 5 days, transfected cells were challenged with ultraviolet light (100 mJ cm
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). Effector caspase (DEVDase) activity was measured using Caspase3/7-Glo (Promega) 18 h after ultraviolet stimulation.
